Drug · DIN 02405458
ZOPICLONE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 12, 2017.
- Drug Identification Number (DIN)
- 02405458
- Company (DIN owner)
- Abri Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Zopiclone N05CF01
- Class
- Human
- Record last updated
- June 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ZOPICLONE | 7.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 18, 2013: NOC 14295Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named ZOPICLONE
- DIN 02282445 · Marketed
- DIN 02344122 · Marketed
- DIN 02385821 · Marketed
- DIN 02385848 · Marketed
- DIN 02321521 · Cancelled Post Market
- DIN 02321548 · Cancelled Post Market
- DIN 02344580 · Cancelled Pre Market
- DIN 02344599 · Cancelled Pre Market
- DIN 02403110 · Approved
- DIN 02403129 · Approved
- DIN 02405431 · Cancelled Pre Market
- DIN 02557223 · Approved
- DIN 02557231 · Approved
- DIN 02557258 · Approved